Disruption of the maxi-K-caveolin-1 interaction alters current expression in human myometrial cells

Reproductive Biology and Endocrinology

Volumn 7, Issue , 2009, Pages

  Brainard, Adam M ^a   Korovkina, Victoria P ^a   England, Sarah K ^a  

^a UNIVERSITY OF IOWA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CAVEOLIN 1; LARGE CONDUCTANCE CALCIUM ACTIVATED POTASSIUM CHANNEL; SMALL INTERFERING RNA; CAV1 PROTEIN, HUMAN; MUTANT PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; BINDING SITE; CARBOXY TERMINAL SEQUENCE; CELL CULTURE; CELL DISRUPTION; CELL ISOLATION; CESAREAN SECTION; CONTROLLED STUDY; FEMALE; FIBROBLAST; GENE MUTATION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOFLUORESCENCE; IMMUNOPRECIPITATION; MOUSE; MYOMETRIUM; NONHUMAN; PATCH CLAMP; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; SMOOTH MUSCLE FIBER; WESTERN BLOTTING; ANIMAL; CELL MEMBRANE POTENTIAL; CHEMISTRY; DRUG ANTAGONISM; DRUG EFFECT; GENETICS; METABOLISM; PHYSIOLOGY; PREGNANCY; PROTEIN BINDING; PROTEIN DOMAIN; PROTEIN MOTIF;

AMINO ACID MOTIFS; ANIMALS; BINDING SITES; CAVEOLIN 1; CELLS, CULTURED; FEMALE; HUMANS; LARGE-CONDUCTANCE CALCIUM-ACTIVATED POTASSIUM CHANNELS; MEMBRANE POTENTIALS; MICE; MUTANT PROTEINS; MYOMETRIUM; PREGNANCY; PROTEIN BINDING; PROTEIN INTERACTION DOMAINS AND MOTIFS; RNA, SMALL INTERFERING;

EID: 71549157744     PISSN: None     EISSN: 14777827     Source Type: Journal    
DOI: 10.1186/1477-7827-7-131     Document Type: Article

References (30)

1. Jackson WF. Ion channels and vascular tone. Hypertension 2000, 35(1 Pt 2):173-178. 1382026, 10642294.
2. Anwer K, Oberti C, Perez GJ, Perez-Reyes N, McDougall JK, Monga M, Sanborn BM, Stefani E, Toro L. Calcium-activated K+ channels as modulators of human myometrial contractile activity. Am J Physiol 1993, 265(4 Pt 1):C976-985.
3. Matharoo-Ball B, Ashford ML, Arulkumaran S, Khan RN. Down-regulation of the alpha- and beta-subunits of the calcium-activated potassium channel in human myometrium with parturition. Biol Reprod 2003, 68(6):2135-2141. 10.1095/biolreprod.102.010454, 12606455.
4. Benkusky NA, Fergus DJ, Zucchero TM, England SK. Regulation of the Ca2+-sensitive domains of the maxi-K channel in the mouse myometrium during gestation. J Biol Chem 2000, 275(36):27712-27719.
5. Zhou XB, Wang GX, Ruth P, Huneke B, Korth M. BK(Ca) channel activation by membrane-associated cGMP kinase may contribute to uterine quiescence in pregnancy. Am J Physiol Cell Physiol 2000, 279(6):C1751-1759.
6. Babiychuk EB, Smith RD, Burdyga T, Babiychuk VS, Wray S, Draeger A. Membrane cholesterol regulates smooth muscle phasic contraction. J Membr Biol 2004, 198(2):95-101. 10.1007/s00232-004-0663-1, 15138749.
7. Brainard AM, Miller AJ, Martens JR, England SK. Maxi-K channels localize to caveolae in human myometrium: a role for an actin-channel-caveolin complex in the regulation of myometrial smooth muscle K+ current. Am J Physiol Cell Physiol 2005, 289(1):C49-57. 10.1152/ajpcell.00399.2004, 15703204.
8. Alioua A, Lu R, Kumar Y, Eghbali M, Kundu P, Toro L, Stefani E. Slo1 Caveolin-binding Motif, a Mechanism of Caveolin-1-Slo1 Interaction Regulating Slo1 Surface Expression. J Biol Chem 2008, 283(8):4808-4817. 10.1074/jbc.M709802200, 18079116.
9. Barbuti A, Gravante B, Riolfo M, Milanesi R, Terragni B, DiFrancesco D. Localization of pacemaker channels in lipid rafts regulates channel kinetics. Circ Res 2004, 94(10):1325-1331. 10.1161/01.RES.0000127621.54132.AE, 15073040.
10. Martens JR, Navarro-Polanco R, Coppock EA, Nishiyama A, Parshley L, Grobaski TD, Tamkun MM. Differential targeting of Shaker-like potassium channels to lipid rafts. J Biol Chem 2000, 275(11):7443-7446. 10.1074/jbc.275.11.7443, 10713042.
11. Martens JR, Sakamoto N, Sullivan SA, Grobaski TD, Tamkun MM. Isoform-specific localization of voltage-gated K+ channels to distinct lipid raft populations. Targeting of Kv1.5 to caveolae. J Biol Chem 2001, 276(11):8409-8414. 10.1074/jbc.M009948200, 11115511.
12. McEwen DP, Li Q, Jackson S, Jenkins PM, Martens JR. Caveolin regulates kv1.5 trafficking to cholesterol-rich membrane microdomains. Mol Pharmacol 2008, 73(3):678-685. 10.1124/mol.107.042093, 18045854.
13. Gabella G. Structure of smooth muscles. Smooth Muscle: An assessment of current knowlege 1981, 1-46. London: Arnold, Bulbring E, Brading AF, Jones AW, Tomita T.
14. Kurzchalia TV, Parton RG. Membrane microdomains and caveolae. Curr Opin Cell Biol 1999, 11(4):424-431. 10.1016/S0955-0674(99)80061-1, 10449327.
15. Li S, Couet J, Lisanti MP. Src tyrosine kinases, Galpha subunits, and H-Ras share a common membrane-anchored scaffolding protein, caveolin. Caveolin binding negatively regulates the auto-activation of Src tyrosine kinases. J Biol Chem 1996, 271(46):29182-29190. 10.1074/jbc.271.46.28995, 8910575.
16. Nevins AK, Thurmond DC. Caveolin-1 functions as a novel Cdc42 guanine nucleotide dissociation inhibitor in pancreatic beta-cells. J Biol Chem 2006, 281(28):18961-18972. 10.1074/jbc.M603604200, 16714282.
17. Kit S, Dubbs DR, Piekarski LJ, Hsu TC. Deletion of Thymidine Kinase Activity from L Cells Resistant to Bromodeoxyuridine. Exp Cell Res 1963, 31:297-312. 10.1016/0014-4827(63)90007-7, 14056989.
18. Khan RN, Smith SK, Morrison JJ, Ashford ML. Ca2+ dependence and pharmacology of large-conductance K+ channels in nonlabor and labor human uterine myocytes. Am J Physiol 1997, 273(5 Pt 1):C1721-1731.
19. Khan RN, Smith SK, Morrison JJ, Ashford ML. Properties of large-conductance K+ channels in human myometrium during pregnancy and labour. Proceedings of the Royal Society of London - Series B: Biological Sciences 1993, 251(1330):9-15.
20. Wallner M, Meera P, Ottolia M, Kaczorowski G, Latorre R, Garcia M, Stefani E, Toro L. Characterization and modulation by a β-subunit of a human maxi-KCa channel cloned from myometrium. Receptors and Channels 1995, 3(3):185-199.
21. Darby PJ, Kwan CY, Daniel EE. Caveolae from canine airway smooth muscle contain the necessary components for a role in Ca(2+) handling. Am J Physiol Lung Cell Mol Physiol 2000, 279(6):L1226-1235.
22. Lohn M, Furstenau M, Sagach V, Elger M, Schulze W, Luft FC, Haller H, Gollasch M. Ignition of calcium sparks in arterial and cardiac muscle through caveolae. Circ Res 2000, 87(11):1034-1039.
23. Oh P, McIntosh DP, Schnitzer JE. Dynamin at the neck of caveolae mediates their budding to form transport vesicles by GTP-driven fission from the plasma membrane of endothelium. J Cell Biol 1998, 141(1):101-114. 10.1083/jcb.141.1.101, 2132716, 9531551.
24. Taggart MJ, Leavis P, Feron O, Morgan KG. Inhibition of PKCalpha and rhoA translocation in differentiated smooth muscle by a caveolin scaffolding domain peptide. Exp Cell Res 2000, 258(1):72-81. 10.1006/excr.2000.4891, 10912789.
25. Turi A, Kiss AL, Mullner N. Estrogen downregulates the number of caveolae and the level of caveolin in uterine smooth muscle. Cell Biol Int 2001, 25(8):785-794. 10.1006/cbir.2001.0769, 11482902.
26. Couet J, Li S, Okamoto T, Ikezu T, Lisanti MP. Identification of peptide and protein ligands for the caveolin-scaffolding domain. Implications for the interaction of caveolin with caveolae-associated proteins. J Biol Chem 1997, 272(10):6525-6533. 10.1074/jbc.272.10.6525, 9045678.
27. Wang Y, Yamaguchi K, Wada T, Hata K, Zhao X, Fujimoto T, Miyagi T. A close association of the ganglioside-specific sialidase Neu3 with caveolin in membrane microdomains. J Biol Chem 2002, 277(29):26252-26259. 10.1074/jbc.M110515200, 12011038.
28. Shmygol A, Noble K, Wray S. Depletion of membrane cholesterol eliminates the Ca2+-activated component of outward potassium current and decreases membrane capacitance in rat uterine myocytes. J Physiol 2007, 581(Pt 2):445-456. 10.1113/jphysiol.2007.129452, 2075177, 17331986.
29. Zou S, Jha S, Kim EY, Dryer SE. A novel actin-binding domain on Slo1 calcium-activated potassium channels is necessary for their expression in the plasma membrane. Mol Pharmacol 2008, 73(2):359-368. 10.1124/mol.107.039743, 17989352.
30. Kim EY, Ridgway LD, Dryer SE. Interactions with filamin A stimulate surface expression of large-conductance Ca2+-activated K+ channels in the absence of direct actin binding. Mol Pharmacol 2007, 72(3):622-630. 10.1124/mol.107.038026, 17586600.